A previous study has demonstrated that IL-13 is a mediator, and possibly a therapeutic target, in radiation-induced lung injury, as shown by saturating fraction of the circulating decoy receptor IL-13Rα2 (Chung et al., 2016). The gene discussed is IL13RA2; the disease is injury.